Richtlijn Coeliakie en Dermatitis Herpetiformis - Nederlandse ...
Richtlijn Coeliakie en Dermatitis Herpetiformis - Nederlandse ...
Richtlijn Coeliakie en Dermatitis Herpetiformis - Nederlandse ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Conclusie<br />
niveau 4<br />
De beschikbare literatuur geeft beperkte informatie over de kost<strong>en</strong>effectiviteit<br />
van diverse strategieën voor scre<strong>en</strong>ing van de algem<strong>en</strong>e bevolking.<br />
D m<strong>en</strong>ing werkgroep; Gezondheidsraad 2006<br />
Aanbeveling<br />
Vooralsnog is bevolkingsonderzoek niet geïndiceerd. Om duidelijkheid te krijg<strong>en</strong> over de<br />
w<strong>en</strong>selijkheid, kost<strong>en</strong> <strong>en</strong> bat<strong>en</strong> maar ook nadel<strong>en</strong> van het verricht<strong>en</strong> van<br />
bevolkingsonderzoek op coeliakie zou in e<strong>en</strong> regio in Nederland e<strong>en</strong> onderzoek moet<strong>en</strong><br />
word<strong>en</strong> gestart naar scre<strong>en</strong>ing met e<strong>en</strong> adequate follow-up (5-10 jaar).<br />
Literatuur<br />
• Atkinson K, Tokmakajian S, Watson W, Gregor J. Evaluation of the <strong>en</strong>domysial antibody for<br />
celiac disease: operating properties and associated cost implications in clinical practice. Can J<br />
Gastro<strong>en</strong>terol 1997;11(8):673-7.<br />
• Catassi C, Rätsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Coeliac disease in<br />
the year 2000: exploring the iceberg. Lancet 1994;343:200-3.<br />
• Collin P. Should adults be scre<strong>en</strong>ed for celiac disease? What are the b<strong>en</strong>efits and harms of<br />
scre<strong>en</strong>ing? Gastro<strong>en</strong>terol 2005;128:s104-8,<br />
• Csizmadia CG, Mearin ML, von Blomberg BM et al. An iceberg of childhood coeliac disease in<br />
the Netherlands. Lancet 1999; 353:813.<br />
• Csizmadia CGDS, Mearin ML, Or<strong>en</strong> A et al. Accuracy and cost-effectiv<strong>en</strong>ess of a new strategy<br />
to scre<strong>en</strong> for celiac disease in childr<strong>en</strong> with Down Syndrome. J Pediatr 2000;137:756-61,<br />
• Gezondheidsraad. Jaarbericht bevolkingsonderzoek 2006. D<strong>en</strong> Haag: Gezondheidsraad, 2006;<br />
publicatie nr 2006/10.<br />
• Gomez JC, Selvaggio G, Pizarro B, Viola MJ, La Motta G, Smecuol E, et al. Value of a<br />
scre<strong>en</strong>ing algorithm for celiac disease using tissue transglutaminase antibodies as first level in a<br />
population-based study. American Journal of Gastro<strong>en</strong>terology 2002;97(11):2785-90.<br />
• Harewood GC, Murray JA. Diagnostic approach to a patiënt with suspected celiac disease: a<br />
cost analysis. Dig Dis Sci 2001;46(11):2510-4.<br />
• Hoff<strong>en</strong>berg EJ. Should all childr<strong>en</strong> be scre<strong>en</strong>ed for celiac disease? Gastro<strong>en</strong>terol 2005;128:s98-<br />
103.<br />
• Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH. Preval<strong>en</strong>ce of coeliac disease in<br />
Northern Ireland. Lancet 1997;350:1370.<br />
• Meloni G, Dore A, Fanciulli G, Tanda F, Bottazzo GF. Subclinical coeliac disease in<br />
schoolchildr<strong>en</strong> from Northern Sardinia. Lancet 1999;353:37.<br />
• Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty Ch, Sampson M, Zhang L, Yazdi F,<br />
Mamaladze V, Pan I, McNeil J, Moher D, Mack D, Patel D. Evid<strong>en</strong>ce Report/Technology<br />
Assessm<strong>en</strong>t No. 104. (Prepared by the University of Ottawa Evid<strong>en</strong>ce-based Practice C<strong>en</strong>ter,<br />
under Contract No. 290-02-0021,) AHRQ Publication No. 04-E029-2, Rockville, MD: Ag<strong>en</strong>cy for<br />
Healthcare Research and Quality. July 2004.<br />
• Shamir R, Hernell O, Leshno M. Cost-effectiv<strong>en</strong>ess analysis of scre<strong>en</strong>ing for celiac disease in<br />
the adult population. Med Decis Making. 2006 May-Jun;26(3):282-93.<br />
• Sneeuw KCA, Brodin H, Bröker M, Verkerk PH, Czismadia CGDS, Mearin ML, Verloove-<br />
Vanhorick. Scre<strong>en</strong>ing for celiac disease in the Netherlands: estimation of costs and b<strong>en</strong>efits.<br />
Eindrapportage Praev<strong>en</strong>tiefonds project nr.28-2229. TNO report 2001,115<br />
<strong>Richtlijn</strong> <strong>Coeliakie</strong> <strong>en</strong> <strong>Dermatitis</strong> <strong>Herpetiformis</strong>, 2008 43